期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
TCM-based new drug discovery and development in China 被引量:16
1
作者 WU Wan-Ying HOU Jin-Jun +3 位作者 LONG Hua-Li YANG Wen-Zhi LIANG Jian GUO De-An 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2014年第4期241-250,共10页
Over the past 30 years, China has significantly improved the drug development environment by establishing a series of policies for the regulation of new drug approval. The regulatory system for new drug evaluation and... Over the past 30 years, China has significantly improved the drug development environment by establishing a series of policies for the regulation of new drug approval. The regulatory system for new drug evaluation and registration in China was gradually developed in accordance with international standards. The approval and registration of TCM in China became as strict as those of chemical drugs and biological products. In this review, TCM-based new drug discovery and development are introduced according to the TCM classification of nine categories. 展开更多
关键词 china china food and drug administration(cfda) Traditional Chinese Medicine Regulatory classification drug discovery drug development
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部